See also this year's filing and all EDGAR filings for this company.
PDF Report 0001344413_2016_Alexza_Pharmaceuticals_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001344413, Alexza Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 10,992,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,320,000 |
| 3 | remainder_Assets | 419,000 |
| 4 | LiabilitiesCurrent | 58,198,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,747,063 |
| 9 | ResearchAndDevelopmentExpense | 11,845,165 |
| 10 | remainder_Expenses | 5,692,166 |
| 11 | remainder_Revenues | 5,193,194 |
| 12 | remainder_NetIncome | 13,000 |
| 13 | remainder_ComprehensiveNetIncome | 2,999 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 14,731,000 |
| 1 | Liabilities | 58,198,000 |
| 2 | Expenses | 29,284,394 |
| 3 | Revenues | 5,193,194 |
| 4 | StockholdersEquity | -43,467,000 |
| 5 | NetIncome | -24,078,200 |
| 6 | ComprehensiveNetIncome | -24,076,700 |
| 7 | BaseVar | 53,711,294 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.26 |
| 9 | EconomicCapitalRatio | 0.603 |
Edgar->Model Mapping
Feature Distribution
Change over Time
